| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $222.19 | $1,333,150.20 | -3.8% | +0.8% | +57.8% | |
| Sep 21, 2023 | SCLX Scilex Holding Co | Sorrento Therapeutics, Inc.45 | 10% Owner | Sell | 60,068,585 | $0.00 | - | -96.9% | -25.7% | -42.9% | |
| Sep 21, 2023 | DERM Journey Medical Corp | Paley Jeffrey59 | Director | Buy | 30,000 | $2.97 | $89,100.00 | +109.2% | +153.9% | +70.0% | |
| Sep 21, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 5,000 | $2.01 | $10,071.50 | - | - | - | |
| Sep 20, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 27,450 | $2.01 | $55,223.91 | - | - | - | |
| Sep 20, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 742 | $1.25 | $923.79 | -1.1% | +103.5% | +52.2% | |
| Sep 20, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 15,504 | $6.27 | $97,210.08 | -8.4% | +41.4% | +173.3% | |
| Sep 20, 2023 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 6,794 | $6.28 | $42,658.17 | -2.2% | +41.4% | +173.3% | |
| Sep 20, 2023 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $14.60 | $292,076.29 | +0.3% | -28.7% | +228.4% | |
| Sep 19, 2023 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 75 | $6.51 | $488.25 | -0.1% | +15.2% | +52.9% | |
| Sep 19, 2023 | TKNO Alpha Teknova, Inc. | Terrill Damon | General Counsel And CCO | Buy | 27,027 | $1.85 | $49,999.95 | +193.1% | +108.4% | +179.9% | |
| Sep 19, 2023 | TKNO Alpha Teknova, Inc. | MacKowski J Matthew | Director | Buy | 810,810 | $1.85 | $1,499,998.50 | New | +108.4% | +179.9% | |
| Sep 19, 2023 | TKNO Alpha Teknova, Inc. | Gunstream Stephen47 | President And CEO | Buy | 54,054 | $1.85 | $99,999.90 | +49.7% | +108.4% | +179.9% | |
| Sep 19, 2023 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 10,045 | $6.31 | $63,383.95 | -100% | +38.5% | +161.4% | |
| Sep 19, 2023 | TKNO Alpha Teknova, Inc. | Lowell Matthew50 | Chief Financial Officer | Buy | 54,054 | $1.85 | $99,999.90 | +159.0% | +108.4% | +179.9% | |
| Sep 19, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 15,000 | $2.02 | $30,349.50 | - | - | - | |
| Sep 19, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 10,596 | $6.31 | $66,860.76 | -65.9% | +38.5% | +161.4% | |
| Sep 19, 2023 | TKNO Alpha Teknova, Inc. | Telegraph Hill Partners Iv, L.P. | 10% Owner | Buy | 8,108,107 | $1.85 | $14,999,997.95 | +46.3% | +108.4% | +179.9% | |
| Sep 19, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.81 | $3,090,616.61 | -1.5% | -14.1% | -0.0% | |
| Sep 18, 2023 | PLSH Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO | Buy | 20,000 | $0.24 | $4,730.00 | +1.3% | - | - | |
| Sep 18, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $179.58 | $165,752.34 | -3.6% | +9.5% | +8.9% | |
| Sep 18, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 25,000 | $2.06 | $51,600.00 | - | - | - | |
| Sep 18, 2023 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 77,800 | $0.91 | $70,500.38 | -1.0% | - | - | |
| Sep 15, 2023 | LNTH Lantheus Holdings, Inc. | Niedzwiecki Daniel54 | See Remarks | Sell | 2,846 | $66.43 | $189,059.78 | -4.1% | +20.2% | +62.9% | |
| Sep 15, 2023 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 9,905 | $180.15 | $1,784,385.75 | -26.5% | +11.0% | +6.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.